Unlocking the potential of engineered immune cell therapy for solid tumors - Nature Communications Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellula...

Terrific #ImmunoEngineering #AdoptiveTcellTherapy #Tcells Update from @vicalbarran.bsky.social et al at @nature.com communications | OPEN ACCESS | Online Now | #CARTcells | #TILs | #TCR | #immunotherapy | #immunoncology |

www.nature.com/articles/s41...

Terrific @natrevcancer.bsky.social article #immunotherapy #immunoncology

YouTube Share your videos with friends, family, and the world.

a few of my #immunoncology and #celltherapy talks

studio.youtube.com/channel/UCXI...

plus bonus features "The dog and I..." series

ClinicalTrials.gov

Xencor has terminated developed of IL-12-Fc, a reduced potency cytokine fusion protein. #XmAb662 had been in a solid tumor basket study with #pembrolizumab.
$XNCR #biosky #biotech #immunoncology
clinicaltrials.gov/study/NCT059...

Miguel Reis Ferreira presented on the topic on the cancer microbiome. He opened by flagging the recent addition of the microbiome to the “Hallmarks of Cancer”.

Meriem Bahri talked about therapeutically targeting macrophages

Felipe Galvez Cancino told us about regulatory T cells in brain tumours. This is a wide view showing some of the size of the lecture theatre. It fits ~400. 350 people are registered for this event, with a turnout of 70-80% so far…

Now we are zoomed in and can see Felipe behind the lecturn mid-talk. Felipe shared the news that he will be moving from UCL to Oxford and will soon have vacancies in his new team to fill.

A taste of some of the research we heard about during Day 1. #CancerResearch #microbiome #immunoncology #biologicaltherapies